| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| lorazepam | Tablet, uncoated | 1 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| oxycodone | Suppository, compressed | 30 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 10 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| sulfamethoxazole~trimethoprim | Tablet, uncoated | 800 mg~160 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| lansoprazole | Tablet, orally disintegrating | 15 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| hydrocortisone | Tablet, uncoated | 20 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| metoprolol tartrate | Tablet, uncoated | 50 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 40 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 20 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 30 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 10 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, hard | 60 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 23/05/2025 |
| spironolactone | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| imipramine hydrochloride | Tablet, sugar coated | 25 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| gemfibrozil | Tablet, film coated | 600 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| reboxetine mesilate | Tablet, uncoated | 5.224 mg | Current | Unavailable | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 20 mg | Anticipated | Available | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 30 mg | Anticipated | Available | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Current | Limited Availability | Manufacturing | 23/05/2025 |
| adrenaline (epinephrine) acid tartrate | Injection, solution | 182 microgram/mL | Resolved | Available | Manufacturing | 22/05/2025 |
| leuprorelin acetate~bicalutamide | Injection, modified release~Tablet, film coated | 22.5 mg~50 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/05/2025 |
| bicalutamide~leuprorelin acetate | Injection, modified release~Tablet, film coated | 50 mg~7.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/05/2025 |
| bicalutamide~leuprorelin acetate | Injection, modified release~Tablet, film coated | 50 mg~22.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/05/2025 |
| hydromorphone hydrochloride | Injection, solution | 2 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/05/2025 |
| hydromorphone hydrochloride | Injection, solution | 10 mg/mL | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 22/05/2025 |
| ceftazidime pentahydrate~avibactam sodium | Injection, powder for | 2329.7 mg~543.5 mg | Current | Limited Availability | Unexpected increase in consumer demand | 22/05/2025 |
| foscarnet sodium | Injection, solution | 24 mg/mL | Current | Limited Availability | Manufacturing | 22/05/2025 |
| daptomycin | Injection, powder for | 500 mg | Current | Limited Availability | Manufacturing | 22/05/2025 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 21/05/2025 |
| fludarabine phosphate | Injection, powder for | 50 mg | Current | Unavailable | Manufacturing | 21/05/2025 |
| mesalazine | Tablet, enteric coated | 800 mg | Anticipated | Available | Manufacturing | 21/05/2025 |
| Peginterferon alfa2a | Injection, solution | 135 microgram | Anticipated | Available | Unexpected increase in consumer demand | 21/05/2025 |
| Peginterferon alfa2a | Injection, solution | 180 microgram | Current | Unavailable | Unexpected increase in consumer demand | 21/05/2025 |
| gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 20/05/2025 |
| clonazepam | Oral Liquid, solution | 2.5 mg/mL | Resolved | Available | Manufacturing | 20/05/2025 |
| methotrexate | Tablet, uncoated | 2.5 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 20/05/2025 |
| ezetimibe~simvastatin | Tablet | 10 mg~20 mg | Anticipated | Available | Manufacturing | 20/05/2025 |
| neostigmine methylsulfate | Injection, solution | 2.5 mg | Current | Unavailable | Manufacturing | 20/05/2025 |
| rifampicin | Capsule | 300 mg | Anticipated | Available | Manufacturing | 20/05/2025 |
| esomeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 20/05/2025 |
| dexmedetomidine hydrochloride | Injection, concentrated | 118 microgram/mL | Current | Unavailable | Manufacturing | 20/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Unexpected increase in consumer demand | 20/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 20/05/2025 |
| montelukast sodium | Tablet, film coated | 10.4 mg | Current | Unavailable | Manufacturing | 20/05/2025 |
| finasteride | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 20/05/2025 |
| naproxen | Tablet | 500 mg | Resolved | Available | Manufacturing | 20/05/2025 |
| estradiol hemihydrate | Drug delivery system, transdermal | 1.54 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 20/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 20/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/05/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 20/05/2025 |
| primidone | Tablet, uncoated | 250 mg | Resolved | Available | Manufacturing | 19/05/2025 |
| alendronate sodium trihydrate | Tablet, uncoated | 91.35 mg | Resolved | Available | Manufacturing | 19/05/2025 |
| isosorbide dinitrate | Tablet, uncoated | 5 mg | Resolved | Available | Manufacturing | 19/05/2025 |
| trihexyphenidyl hydrochloride | Tablet, uncoated | 5 mg | Resolved | Available | Unexpected increase in consumer demand | 19/05/2025 |
| carbidopa monohydrate~entacapone~levodopa | Tablet, film coated | 54 mg~200 mg~200 mg | Anticipated | Available | Manufacturing | 19/05/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 150 mg~40.5 mg~200 mg | Anticipated | Available | Manufacturing | 19/05/2025 |
| atropine sulfate monohydrate | Eye Drops, solution | 9.9737 mg/mL | Resolved | Available | Manufacturing | 19/05/2025 |
| salmeterol xinafoate~fluticasone propionate | Inhalation, powder for | 72.5 microgram/actuation~250 microgram/actuation | Anticipated | Available | Manufacturing | 19/05/2025 |
| simvastatin | Tablet, film coated | 80 mg | Resolved | Available | Manufacturing | 19/05/2025 |
| lacosamide | Tablet, film coated | 200 mg | Current | Unavailable | Manufacturing | 19/05/2025 |
| lacosamide | Tablet, film coated | 100 mg | Current | Unavailable | Manufacturing | 19/05/2025 |
| mupirocin calcium | Ointment | 21.5 mg/g | Anticipated | Available | Manufacturing | 19/05/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Manufacturing | 19/05/2025 |
| spironolactone | Tablet, film coated | 100 mg | Current | Unavailable | Manufacturing | 19/05/2025 |
2025年5月26日